An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager
用户ZHpUxjhiFwbk
8天前
33
10
已完结
1. 系统已在2025-04-18 10:47:10对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1002/cpt.3431
文献链接: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3431
其他信息:
出版社: Wiley
作者: Di Zhou; Roman Kischel; Sabine Stienen; Danielle Townsley; Alexander Sternjak; Michael Lutteropp; Julie Bailis; Matthias Friedrich; Benno Rattel; Khamir Mehta; Vijay V. Upreti
